Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons

利用自然和定向进化来剖析人类 L1 逆转录转座子序列变异的功能后果

基本信息

项目摘要

PROJECT SUMMARY Transposable elements have generated the majority of the sequence in the human genome, and all of human biology has evolved in the ever-present DNA, RNA, and protein made by these self-replicating pieces of selfish DNA. The replication of transposable elements constitutes a major source of new mutations in humans which drive genome instability and a variety of genetic diseases. Our group previously discovered the rapid evolution of several restriction factors of Long Interspersed Element-1 (L1), the endogenous retroelements most active in humans. This pattern of evolution suggests that L1s have evolved to evade these restriction factors, driving rapid host evolution to keep pace. However, it is unknown how sequence variation in L1s impacts their ability to evade and replicate in the presence of host restriction factors. We are specifically interested in understanding – have transposable elements evolved to evade the defense mechanisms of the human genome? What are the mechanisms of transposable element evasion? What are the consequences to human health of evasive transposable elements replicating at times and places they are normally repressed? To answer these questions, our lab employs non-traditional combinations of approaches including retrospective analyses of genomes to understand what has happened and prospective experiments to ask what could happen. We propose to leverage the lab’s recently generated, diverse panel of more than 130 young human L1s to search for variation in the ability of L1s to replicate in the presence of otherwise effective host restriction factors. This variation could indicate adaptation of an L1 to evade host restriction or adaptation of the host to restrict evasive L1s. In addition to this retrospective analysis of evolutionary history, we propose to ‘speed up’ evolution by building an in vitro evolution system to select for L1s that evade a defined restriction factor. Comparison of these historical and prospective evolutionary approaches will help us decode the selective pressures that drove L1 and human evolution. This research will address a fascinating basic science question about the mechanisms of L1 evolution in the face of the host innate immune system with impact on our understanding of sporadic autoimmune diseases without a clear genetic contribution. Our lab combines a dedication to mentorship and scientific outreach with effort to build a communicative and accommodating space to enable creative, daring science. Our diverse and experienced team of scientists integrates expertise in comparative genomics, genome evolution, L1 biology, in vitro evolution, and protein evolution and function to bring an evolution-driven approach to the proposed projects. With our record of pushing conceptual and technical boundaries to bring new understanding to the fields of protein evolution and restriction factor biology, our team is uniquely poised to bring about a new understanding of L1 evolution and biology with implications for genome evolution and numerous disease states with clear L1 involvement. (30 lines)
项目总结

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Noel McLaughlin其他文献

Richard Noel McLaughlin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Noel McLaughlin', 18)}}的其他基金

Reverse transcriptase-mediated expansion of the host innate immune system
逆转录酶介导的宿主先天免疫系统扩张
  • 批准号:
    10574416
  • 财政年份:
    2022
  • 资助金额:
    $ 10.03万
  • 项目类别:
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons
利用自然和定向进化来剖析人类 L1 逆转录转座子序列变异的功能后果
  • 批准号:
    10275297
  • 财政年份:
    2021
  • 资助金额:
    $ 10.03万
  • 项目类别:
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons
利用自然和定向进化来剖析人类 L1 逆转录转座子序列变异的功能后果
  • 批准号:
    10634618
  • 财政年份:
    2021
  • 资助金额:
    $ 10.03万
  • 项目类别:
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons
利用自然和定向进化来剖析人类 L1 逆转录转座子序列变异的功能后果
  • 批准号:
    10470839
  • 财政年份:
    2021
  • 资助金额:
    $ 10.03万
  • 项目类别:
Causes and human health consequences of the evolution of retroelements and host restriction factors
逆转录因子和宿主限制因子进化的原因和人类健康后果
  • 批准号:
    8968153
  • 财政年份:
    2015
  • 资助金额:
    $ 10.03万
  • 项目类别:

相似海外基金

Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
  • 批准号:
    MR/Y033701/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
  • 批准号:
    MR/Y001273/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
  • 批准号:
    478933
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
  • 批准号:
    10760885
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
  • 批准号:
    10655219
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
  • 批准号:
    10582053
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
  • 批准号:
    490663
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
  • 批准号:
    488982
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
  • 批准号:
    2889164
  • 财政年份:
    2023
  • 资助金额:
    $ 10.03万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了